Eating Well May Slow Your Biological Clock – And Save Your Life

New research links diet quality to epigenetic aging and mortality risk in tens of thousands of Americans

A growing body of research suggests that aging is not simply measured by the number of birthdays a person has celebrated. While chronological age advances predictably, biological age can move at a very different pace. Some individuals experience accelerated biological decline, while others maintain a younger physiological profile despite being the same chronological age. A major new study published in Aging Cell now provides compelling evidence that diet quality may play a central role in determining how quickly the body ages at the molecular level.

The study, led by Dr. May A. Beydoun and colleagues from the National Institute on Aging, analyzed nearly 4,000 adults from two nationally representative American cohorts to investigate how diet quality influences epigenetic aging and mortality risk. The investigators utilized advanced statistical modeling approaches, including additive Bayesian networks, generalized structural equation models, and four-way decomposition analyses, to explore how dietary patterns, socioeconomic status, biological aging, and mortality are interconnected.

The findings revealed a remarkably consistent pattern: individuals with higher-quality diets tended to exhibit slower epigenetic aging and lower mortality risk, while poor dietary patterns were associated with accelerated biological aging and increased likelihood of death. Importantly, the study also demonstrated that part of diet’s protective effect on survival may operate through its influence on epigenetic aging pathways, particularly through a biomarker known as GrimAge acceleration.

What Is Epigenetic Aging, and Why Does It Matter?

Epigenetics refers to molecular mechanisms that regulate how genes are expressed without altering the underlying DNA sequence itself. Although humans inherit a fixed genome, environmental exposures, lifestyle behaviors, stress, disease, and nutrition continuously modify the way genes are turned on or off throughout life. One of the most extensively studied epigenetic mechanisms is DNA methylation, a process in which methyl groups attach to specific locations within the genome and influence gene activity.

Researchers have discovered that DNA methylation patterns change in highly predictable ways with aging. By analyzing methylation signatures across thousands of genomic sites, scientists developed algorithms known as epigenetic clocks that estimate biological age. When biological age exceeds chronological age, the difference is referred to as epigenetic age acceleration (EAA). Accelerated epigenetic aging has been strongly associated with cardiovascular disease, metabolic dysfunction, neurodegenerative disorders, cancer, frailty, and all-cause mortality.

The current study evaluated five distinct epigenetic aging measures, including the Horvath clock, Hannum clock, PhenoAge, GrimAge, and DunedinPoAm (Table 1). Each captures different dimensions of biological aging. GrimAge was specifically designed to predict mortality risk using methylation signatures linked to plasma proteins and smoking exposure, whereas DunedinPoAm measures the ongoing pace of aging rather than static biological age.

Among all biomarkers examined, GrimAge emerged as the strongest predictor of mortality across both study cohorts. Each standard deviation increase in GrimAge acceleration was associated with a 61% increase in mortality risk in NHANES and a 76% increase in mortality risk in the Health and Retirement Study cohort.

Table 1: Epigenetic Clocks

The Healthy Eating Index: Measuring Diet Quality

To assess diet quality, the researchers used the Healthy Eating Index-2015 (HEI-2015), a scoring system developed to measure adherence to the Dietary Guidelines for Americans. Rather than focusing on isolated nutrients, the HEI evaluates overall dietary patterns. Higher scores reflect diets rich in fruits, vegetables, whole grains, seafood, plant proteins, and healthy fats, while lower scores are associated with higher consumption of refined grains, sodium, added sugars, and saturated fats. The maximum possible score is 100.

The investigators calculated HEI-2015 scores differently in the two cohorts. In the Health and Retirement Study, dietary intake was assessed using a validated Harvard Food Frequency Questionnaire that evaluated long-term eating habits over the previous year. NHANES relied on a single 24-hour dietary recall, which is more vulnerable to measurement variability and likely weakened some associations observed in that cohort.

Importantly, this approach recognizes that human diets function as integrated biological systems rather than collections of isolated nutrients. Dietary patterns such as the Mediterranean diet generally score highly on HEI-2015 assessments because they emphasize nutrient-dense whole foods and anti-inflammatory dietary components.

Two Cohorts, One Consistent Story

The study examined two nationally representative cohorts. The first included 2,158 adults from NHANES aged 50 years and older, followed from 1999–2002 through 2019. The second included 1,752 participants from the Health and Retirement Study followed from 2016 through 2022. Both cohorts were linked to the National Death Index, allowing investigators to precisely determine mortality outcomes over time.

The cohorts differed in several important ways. Participants in the Health and Retirement Study were older on average, with a mean age of approximately 69 years compared with 64 years in NHANES. HRS also used a more comprehensive dietary assessment tool and had a shorter follow-up period. Despite these methodological differences, both cohorts demonstrated broadly similar relationships among diet quality, epigenetic aging, socioeconomic status, and mortality.

Kaplan–Meier survival analyses demonstrated that individuals with accelerated epigenetic aging experienced substantially worse survival outcomes over time. Biological aging markers such as GrimAge and DunedinPoAm consistently separated survival curves across tertiles, highlighting their strong association with mortality risk.

The Central Finding: Diet, Aging, and Death Are Deeply Linked

The central finding of the study was strikingly consistent across multiple analytical approaches. Higher diet quality was associated with lower epigenetic age acceleration and reduced mortality risk, while poor diet quality correlated with faster biological aging and increased mortality. These associations were particularly strong for GrimAge and DunedinPoAm, the two clocks most tightly linked to lifespan prediction.

In multivariable-adjusted Cox proportional hazards models, higher HEI-2015 scores were inversely associated with mortality. In NHANES, each standard deviation increase in HEI score corresponded to an 11% reduction in mortality risk, while in HRS the reduction reached 25%.

The study also found that lower socioeconomic status was strongly associated with both poorer diet quality and accelerated epigenetic aging. These relationships remained evident even after adjustment for demographic variables. The consistency across statistical models strengthened confidence that the observed associations reflected genuine biological and epidemiological relationships rather than isolated statistical artifacts.

Tracing the Pathway: Does Diet Work Through Epigenetic Aging?

One of the most innovative aspects of the study involved determining whether epigenetic aging mediates the relationship between diet quality and mortality. To address this question, the investigators used a sophisticated analytical framework called four-way decomposition, which partitions the relationship into direct effects, indirect effects, and interaction effects.

In the HRS cohort, approximately 44% of the protective association between higher diet quality and lower mortality was statistically explained by GrimAge acceleration. This suggests that nearly half of diet’s beneficial effect on survival may operate through mechanisms influencing epigenetic aging.

When the investigators tested the reverse hypothesis — whether epigenetic aging influences mortality primarily through diet quality — the evidence was weak. This finding supports the interpretation that diet influences epigenetic aging, which subsequently affects mortality risk, rather than the reverse sequence.

The analysis also revealed a notable interaction involving PhenoAge. Approximately 22% of the mortality association appeared attributable to interactions between diet quality and PhenoAge, suggesting that healthy dietary patterns may partially buffer the mortality risks associated with inflammatory and metabolic aging phenotypes.

The Complicating Role of Physical Activity

The relationship between diet and longevity became more nuanced when the investigators adjusted for additional lifestyle factors such as smoking, alcohol intake, total caloric intake, and physical activity. In these sensitivity analyses, the overall association between diet quality and mortality was attenuated and no longer statistically significant in the HRS cohort. Physical activity emerged as the dominant confounding variable.

This does not suggest that diet lacks importance. Rather, it illustrates the reality that healthy lifestyle behaviors cluster together. Individuals who consume higher-quality diets are also more likely to exercise regularly, avoid smoking, maintain healthier body composition, and engage in other behaviors that collectively influence survival.

Even after these adjustments, however, the mediating role of GrimAge remained statistically significant, indicating that diet still appears to influence biological aging pathways independently of physical activity to some extent.

Socioeconomic Status: The Upstream Driver

A particularly important aspect of the study was the recognition that socioeconomic status functions as a major upstream determinant of both diet quality and biological aging. Using educational attainment and income variables, the investigators created a composite socioeconomic status index and demonstrated strong relationships between lower SES, poorer diet quality, and accelerated epigenetic aging.

Additive Bayesian network analyses revealed that Non-Hispanic Black and Hispanic participants were more likely to experience lower SES scores, which in turn were associated with poorer dietary quality and faster biological aging. Importantly, socioeconomic status also influenced biological aging through pathways that extended beyond diet alone.

These findings reinforce the idea that biological aging is deeply embedded within broader social determinants of health. Chronic stress, healthcare access, environmental exposures, food insecurity, and neighborhood conditions all likely contribute to epigenetic changes that accelerate aging processes.

The study therefore highlights an important public health reality: improving dietary behavior cannot be fully separated from addressing the socioeconomic conditions that shape food access and lifestyle opportunities.

How Might Diet Actually Change Your Epigenome?

The biological mechanisms linking diet quality to epigenetic aging are increasingly supported by experimental and clinical evidence. High-quality diets rich in fruits, vegetables, whole grains, legumes, seafood, and healthy fats reduce oxidative stress and chronic systemic inflammation, two hallmarks of aging biology.

Inflammatory signaling pathways, particularly NF-κB, influence DNA methylation patterns throughout the genome. Chronic activation of inflammatory pathways can alter the epigenome in ways that accelerate biological aging. In contrast, antioxidant-rich and anti-inflammatory dietary patterns may help preserve healthier methylation signatures.

GrimAge incorporates methylation-based surrogates for proteins such as plasminogen activator inhibitor-1 (PAI-1), growth differentiation factor-15 (GDF-15), and leptin, all of which are strongly associated with vascular dysfunction, inflammation, metabolic stress, and mortality risk. Healthier dietary patterns likely reduce the biological signals that drive these markers, thereby slowing GrimAge acceleration.

Similarly, PhenoAge incorporates biomarkers linked to inflammation, glucose regulation, immune function, and metabolic health. Better diet quality may improve glycemic control and inflammatory regulation, reducing the mortality risks associated with elevated PhenoAge profiles.

What This Study Can and Cannot Tell Us

Despite the strength of the findings, the investigators emphasized several important limitations. Most importantly, this was an observational study. Participants were not randomly assigned to dietary interventions, meaning causation cannot be definitively established.

Additional methodological limitations included reliance on single time-point epigenetic measurements and, in NHANES, the use of a single 24-hour dietary recall that likely underestimated true dietary patterns. In the HRS cohort, dietary data were collected several years before epigenetic measurements, complicating precise temporal interpretation.

Furthermore, lifestyle factors such as exercise, smoking, alcohol consumption, sleep quality, stress, and environmental exposures interact extensively with dietary habits. Human aging is multifactorial, and diet represents only one component of a much larger biological and behavioral network.

Nevertheless, the consistency of findings across two independent national cohorts, multiple epigenetic clocks, and several advanced analytical methods substantially strengthens the overall conclusions of the study.

The Bigger Picture

This study represents one of the most comprehensive investigations to date examining how dietary behavior may influence biological aging at the molecular level. The findings suggest that diet quality affects not only traditional health markers such as cholesterol, blood pressure, and body weight, but also the pace at which cells age biologically.

The observation that GrimAge both predicts mortality and mediates part of diet’s effect on survival raises the possibility that epigenetic biomarkers could eventually become tools for monitoring the biological impact of nutritional interventions. In the future, clinicians may potentially track whether dietary changes are slowing a patient’s biological aging trajectory in real time.

For now, the practical implications remain remarkably clear. Diets emphasizing fruits, vegetables, whole grains, plant proteins, seafood, and healthy fats appear consistently associated with slower biological aging and improved survival outcomes. Poor dietary patterns rich in processed foods, refined sugars, saturated fats, and excessive sodium appear to accelerate molecular aging processes that ultimately influence lifespan.

The study’s authors appropriately describe their findings as hypothesis-generating and call for additional longitudinal and interventional research. However, the evidence presented strongly suggests that the foods consumed daily may influence not only immediate health but also the molecular mechanisms governing how quickly the human body ages. Your biological clock, it appears, may be shaped in part by what is placed on the dinner plate.

Reference

Beydoun, M. A., M. T.Fanelli Kuczmarski, N.Noren Hooten, et al. 2026. “Healthy Eating Index, Epigenetic Age Acceleration and Mortality Risk in US Adults.” Aging Cell25, no. 5: e70504. https://doi.org/10.1111/acel.70504.

Image credit: Portions of the figure in this article were generated using ChatGPT (OpenAI) or Google Gemini.

Disclaimer: This blog post is intended solely for educational and scientific informational purposes. Any mention of therapeutic drug names, including FDA-approved medications, is for the purpose of accurate reporting and discussion of biomedical research and does not constitute medical advice, endorsement, or promotion. Readers should not interpret the content as a recommendation for any specific treatment. Always consult a qualified healthcare professional for medical advice or treatment decisions.

About Marin Biologic Laboratories

Our Recent Publication/Meeting Presentation on Gene Therapy

1. Development of VNX-101, an Adeno-Associated Virus with Less Immunogenicity and Efficient Long-Term Expression of a CD19 T-Cell Engager. Molecular Therapy Methods & Clinical Development, published online July 24, 2025.

3. Cell-Based Potency Assay for Anti-CD3-Anti-CD19 Diabody. Journal of Immunological Methods. 2025. 545-114004.

3. Development of a Pharmacokinetic (PK) Mouse Serum GLP ELISA for an Anti–CD19–AntiCD3 Diabody
bioRxiv 2025.03.19.644217; doi: https://doi.org/10.1101/2025.03.19.644217.

4. American Society of Hematology (ASH) Annual Meeting 2024.
Abstract link: Using Gene Therapy to Solve Challenges with CAR-T Cell Immunotherapy: Lead Selection and Preclinical Development of an Adeno-Associated Virus with Reduced Immunogenicity Exhibiting Efficient and Long-Term Expression of an Anti-CD19 T-Cell Engager.

Comprehensive Assay Solutions for In Vitro and Cell Based Potency Assays and Pharmacokinetics Studies- Our Expertise

With 30 years of expertise in cell culture, cell-based assays, and preclinical/clinical PK/PD analysis, we specialize in offering assay services essential for a wide variety of therapeutic drug development programs, preclinical studies, IND/BLA applications, and commercialization. Our comprehensive services include both preclinical non-GLP and GLP assays, as well as non-GMP and GMP assays, providing critical support throughout the entire development pipeline.

Watch the following video and explore our latest presentation on the development and validation of potency and pharmacokinetic (PK) assays for AAV vectors, highlighting innovative methodologies and industry-leading expertise.

Download the full presentation: Development of Custom Cell Based and In vitro Potency and Pharmacokinetics (PK) Assays for AAV vectors- Marin biologic Laboratories

Development of Cell-Based Potency Assays: Case Studies and Blogs from Marin Biologic Laboratories (MarinBio)

Drug Discovery & Development Assays Offered by Marin Biologic Laboratories (MarinBio)

• ADME/Tox
• Molecular Biology
• The Art of Cell Culture
• Exosomes
• Stability Services
• Potency Assay
• Gene Therapy Assays
• Immunotherapy Assays
• Antiviral Therapy Assays
• cGMP
• MLR
• Cell Based Assays
• ELISA
• Flow Cytometry
• Protein
• PCR-qPCR
• Immunoassay
• Radioimmunoassay
• GLP
• Transfection
• Cell Therapy Assays
• Targeted Protein Degradation
• Research to Commercialization